Inventor · disambiguated record
Peter P. Sordillo
Also filed as: SORDILLO PETER P · Sordillo Peter
3 granted patents·6 pending applications·4 citations·filing 2015–2022
55Inventor score
Files withSIGNPATH PHARMA INC9
Top patents by PatentIndex Score
9 records- 0185US10485768B2Treatment for glioblastomaSIGNPATH PHARMA INC·Filed 2016·Granted Nov 26, 2019·4 cites·7 claims
- 0259US2020046652A1Treatment for glioblastomaSIGNPATH PHARMA INC·Filed 2019·Application pending·0 cites
- 0358US11813356B2Dosing regimens for treatment of proliferative disordersSIGNPATH PHARMA INC·Filed 2019·Granted Nov 14, 2023·0 cites·10 claims
- 0451US2024180852A1Treatment for malignant pleural effusion in humansSIGNPATH PHARMA INC·Filed 2022·Application pending·0 cites
- 0549US2024091242A1Lipids that reduce lung damage, improve pulmonary function and decrease pro-inflammatory cytokinesSIGNPATH PHARMA INC·Filed 2022·Application pending·0 cites
- 0644US10739353B2Suppression of cytokine release and cytokine stormSIGNPATH PHARMA INC·Filed 2015·Granted Aug 11, 2020·0 cites·19 claims
- 0744US2020360300A1Suppression of Cytokine Release and Cytokine StormSIGNPATH PHARMA INC·Filed 2020·Application pending·0 cites
- 0839US2017252311A1Sphingosine kinase inhibitors and ceramide for maintenance therapy of glioblastomaSIGNPATH PHARMA INC·Filed 2017·Application pending·0 cites
- 0938US2016287532A1Curcumin for treating intervertebral disc diseaseSIGNPATH PHARMA INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Peter P. Sordillo files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →